The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. Bacterial co-infections are associated with unfavourable outcomes in respiratory viral infections; however, microbiological and antibiotic data related to COVID-19 are sparse. Adequate use of antibiotics in line with antibiotic stewardship (ABS) principles is warranted during the pandemic. We performed a retrospective study of clinical and microbiological characteristics of 140 COVID-19 patients admitted between February and April 2020 to a German University hospital, with a focus on bacterial co-infections and antimicrobial therapy. The final date of follow-up was 6 May 2020. Clinical data of 140 COVID-19 patients were recorded: The median age was 63.5 (range 17–99) years; 64% were males. According to the implemented local ABS guidelines, the most commonly used antibiotic regimen was ampicillin/sulbactam (41.5%) with a median duration of 6 (range 1–13) days. Urinary antigen tests for Legionella pneumophila and Streptococcus peumoniae were negative in all cases. In critically ill patients admitted to intensive care units ( n = 50), co-infections with Enterobacterales (34.0%) and Aspergillus fumigatus (18.0%) were detected. Blood cultures collected at admission showed a diagnostic yield of 4.2%. Bacterial and fungal co-infections are rare in COVID-19 patients and are mainly prevalent in critically ill patients. Further studies are needed to assess the impact of antimicrobial therapy on therapeutic outcome in COVID-19 patients to prevent antimicrobial overuse. ABS guidelines could help in optimising the management of COVID-19. Investigation of microbial patterns of infectious complications in critically ill COVID-19 patients is also required. Supplementary Information The online version of this article (10.1007/s10096-020-04063-8) contains supplementary material, which is available to authorized users.
【저자키워드】 COVID-19, antibiotic stewardship, Diagnostic stewardship, bacterial co-infections, 【초록키워드】 coronavirus disease, SARS-CoV-2, coronavirus, pandemic, hospital, intensive care unit, diagnostic, Local, outcome, Antigen, Spread, Retrospective study, Critically ill, Characteristics, clinical, management, therapeutic, Co-infection, Antimicrobial therapy, Follow-up, university, Legionella pneumophila, Admission, bacterial co-infection, fungal, critically ill patients, Aspergillus fumigatus, antibiotic, investigation, COVID-19 patient, microbial, regimen, Critically ill patient, acute respiratory syndrome, supplementary material, median age, help, Final, blood culture, Streptococcus, urinary, Prevent, males, respiratory viral, prevalent, performed, collected, caused, required, median, Adequate, ampicillin/sulbactam, infectious complication, use of antibiotics, 【제목키워드】 bacterial co-infection, antibiotic, retrospective cohort study, Rate,